Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 4:02 pm Sale |
2022-12-31 | 13G | The Carlyle Group Inc. CG |
David M. Rubenstein | 29,249,644 8.100% |
-2,000,000 (-6.40%) |
Filing History |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | The Carlyle Group Inc. CG |
The Vanguard Group | 24,952,869 6.860% |
6,031,921 (+31.88%) |
Filing History |
| 2023-02-08 2:29 pm Purchase |
2022-12-30 | 13G | The Carlyle Group Inc. CG |
MORGAN STANLEY MS |
23,412,646 6.400% |
5,188,324 (+28.47%) |
Filing History |
| 2023-01-31 4:15 pm Purchase |
2023-01-27 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
876,189 8.000% |
313,333 (+55.67%) |
Filing History |
| 2023-01-23 5:15 pm Purchase |
2023-01-12 | 13D | Carlyle Credit Income Fund CCIF |
Carlyle Group Inc. CG |
3,718,256 35.800% |
3,718,256 (New Position) |
Filing History |
| 2022-12-20 4:30 pm Sale |
2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
-1,224,571 (Position Closed) |
Filing History |
| 2022-08-29 5:27 pm Purchase |
2022-08-17 | 13G | MKS Instruments, Inc. MKSI |
Carlyle Group Inc. CG |
8,482,732 12.800% |
8,482,732 (New Position) |
Filing History |
| 2022-08-11 5:03 pm Purchase |
2022-08-01 | 13D | Exicure, Inc. XCUR |
Carlyle Group Inc. CG |
57,086 5.700% |
57,086 (New Position) |
Filing History |
| 2022-08-11 5:01 pm Purchase |
2022-08-01 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,970,156 11.100% |
2,970,156 (New Position) |
Filing History |
| 2022-08-11 5:00 pm Purchase |
2022-08-01 | 13D | Adicet Bio, Inc. ACET |
Carlyle Group Inc. CG |
2,152,959 5.400% |
2,152,959 (New Position) |
Filing History |
| 2022-08-11 4:58 pm Purchase |
2022-08-01 | 13D | NuCana plc NCNA |
Carlyle Group Inc. CG |
134,125 6.400% |
134,125 (New Position) |
Filing History |
| 2022-08-11 4:56 pm Purchase |
2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,224,571 15.300% |
1,224,571 (New Position) |
Filing History |
| 2022-08-11 4:55 pm Purchase |
2022-08-01 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
Carlyle Group Inc. CG |
193,196 11.700% |
193,196 (New Position) |
Filing History |
| 2022-08-11 4:52 pm Purchase |
2022-08-01 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Carlyle Group Inc. CG |
208,796 8.500% |
208,796 (New Position) |
Filing History |
| 2022-08-11 4:50 pm Purchase |
2022-08-01 | 13D | Spruce Biosciences, Inc. SPRB |
Carlyle Group Inc. CG |
1,802,518 7.700% |
1,802,518 (New Position) |
Filing History |
| 2022-08-11 4:47 pm Purchase |
2022-08-01 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
562,856 15.400% |
562,856 (New Position) |
Filing History |
| 2022-07-27 4:31 pm Purchase |
2021-12-31 | 13D | CommScope Holding Company, Inc. COMM |
Carlyle Group Inc. CG |
39,468,542 16.000% |
3,104,942 (+8.54%) |
Filing History |
| 2022-06-14 4:41 pm Sale |
2022-06-09 | 13D | The Carlyle Group Inc. CG |
Carlyle Group Management L.L.C. | 152,131,004 42.100% |
-3,724,382 (-2.39%) |
Filing History |
| 2022-06-06 5:17 pm Purchase |
2022-05-27 | 13D | QuidelOrtho Corporation QDEL |
Carlyle Group Inc. CG |
12,460,183 18.600% |
12,460,183 (New Position) |
Filing History |
| 2022-02-14 2:33 pm Sale |
2021-12-31 | 13G | The Carlyle Group Inc. CG |
Vulcan Value Partners, LLC | 16,609,123 4.660% |
-8,810,166 (-34.66%) |
Filing History |